Actively Recruiting
Investigation of Brain Blood Flow and Ischaemic Lesions After Acute Intracerebral Haemorrhage Using Transcranial Doppler and MRI
Led by University of Leicester · Updated on 2024-09-19
120
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating how and why inadequate blood flow in the brain occurs after bleeding caused by intracerebral haemorrhage ICH, a type of stroke. This observational study focuses on the effects of blood pressure lowering treatment, which aims to stop bleeding but may also reduce blood flow and cause blockages in brain vessels. The study seeks to understand the relationship between blood pressure changes, fast breathing, and brain blood flow to better explain potential brain injury after ICH. Participants will undergo non-invasive brain blood flow assessments using transcranial Doppler ultrasonography TCD within 48 hours of hospital admission and again 4 to 7 days after ICH onset. Additionally, they will have an MRI scan more than 7 days after the stroke. The TCD measures blood velocity in key brain arteries along with blood pressure, heart rate, and carbon dioxide levels. No treatment is given as part of the study researchers observe natural changes in cerebral blood flow and related factors. During the study, participants will have initial and follow-up TCD assessments and an MRI scan to measure cerebral blood velocity and carbon dioxide levels. Data collected will be analyzed to understand cerebral blood flow changes and how they relate to tissue damage seen on MRI. The study tracks these measurements from enrollment through the follow-up period of about 7 days post-stroke. This helps researchers learn more about brain blood flow after hemorrhagic stroke and its role in brain injury.
CONDITIONS
Brief Title
Ischaemic Lesions in Acute Intracerebral Haemorrhage
Research Team
J
Jatinder Minhas, SFHEA
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here